Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21414779rdf:typepubmed:Citationlld:pubmed
pubmed-article:21414779lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:21414779lifeskim:mentionsumls-concept:C0140080lld:lifeskim
pubmed-article:21414779lifeskim:mentionsumls-concept:C0202220lld:lifeskim
pubmed-article:21414779lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:21414779lifeskim:mentionsumls-concept:C1880355lld:lifeskim
pubmed-article:21414779pubmed:issue8lld:pubmed
pubmed-article:21414779pubmed:dateCreated2011-4-4lld:pubmed
pubmed-article:21414779pubmed:abstractTextThe insulin-like growth factor-1 receptor (IGF-1R) plays an important role in the regulation of cell growth and differentiation, and in protection from apoptosis. IGF-1R has been shown to be an appealing target for the treatment of human cancer. Herein, we report the synthesis, structure-activity relationships (SAR), X-ray cocrystal structure and in vivo tumor study results for a series of 2,4-bis-arylamino-1,3-pyrimidines.lld:pubmed
pubmed-article:21414779pubmed:languageenglld:pubmed
pubmed-article:21414779pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21414779pubmed:citationSubsetIMlld:pubmed
pubmed-article:21414779pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21414779pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21414779pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21414779pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21414779pubmed:statusMEDLINElld:pubmed
pubmed-article:21414779pubmed:monthAprlld:pubmed
pubmed-article:21414779pubmed:issn1464-3405lld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:EschJ FJFlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:KumarRakeshRlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:HuangXinXlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:SunJi-RongJRlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:GuYanYlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:RadinskyRober...lld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:LuJohnJlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:JonaJananJlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:ZhaoHuilinHlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:ZhuXiaotianXlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:GallantPaulPlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:SurapaneniSek...lld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:BuchananJohn...lld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:ChaiLillyLlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:EpsteinLinda...lld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:MorrisonMicha...lld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:NovakPerry...lld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:TurciSusan...lld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:RosePaul EPElld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:ChaffeeStuart...lld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:CupplesRodRlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:HarmangeJean-...lld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:JunH ToniHTlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:CarneyDavid...lld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:NewcombJohn...lld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:YanezEvelynElld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:HoukBrett EBElld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:JosephSmritiSlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:SawantSatinSlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:XuKeyangKlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:HodgeKathyKlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:MengesTomTlld:pubmed
pubmed-article:21414779pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:21414779pubmed:copyrightInfoCopyright © 2011 Elsevier Ltd. All rights reserved.lld:pubmed
pubmed-article:21414779pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21414779pubmed:day15lld:pubmed
pubmed-article:21414779pubmed:volume21lld:pubmed
pubmed-article:21414779pubmed:ownerNLMlld:pubmed
pubmed-article:21414779pubmed:authorsCompleteYlld:pubmed
pubmed-article:21414779pubmed:pagination2394-9lld:pubmed
pubmed-article:21414779pubmed:meshHeadingpubmed-meshheading:21414779...lld:pubmed
pubmed-article:21414779pubmed:meshHeadingpubmed-meshheading:21414779...lld:pubmed
pubmed-article:21414779pubmed:meshHeadingpubmed-meshheading:21414779...lld:pubmed
pubmed-article:21414779pubmed:meshHeadingpubmed-meshheading:21414779...lld:pubmed
pubmed-article:21414779pubmed:meshHeadingpubmed-meshheading:21414779...lld:pubmed
pubmed-article:21414779pubmed:meshHeadingpubmed-meshheading:21414779...lld:pubmed
pubmed-article:21414779pubmed:meshHeadingpubmed-meshheading:21414779...lld:pubmed
pubmed-article:21414779pubmed:meshHeadingpubmed-meshheading:21414779...lld:pubmed
pubmed-article:21414779pubmed:meshHeadingpubmed-meshheading:21414779...lld:pubmed
pubmed-article:21414779pubmed:meshHeadingpubmed-meshheading:21414779...lld:pubmed
pubmed-article:21414779pubmed:meshHeadingpubmed-meshheading:21414779...lld:pubmed
pubmed-article:21414779pubmed:meshHeadingpubmed-meshheading:21414779...lld:pubmed
pubmed-article:21414779pubmed:year2011lld:pubmed
pubmed-article:21414779pubmed:articleTitleDiscovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitors.lld:pubmed
pubmed-article:21414779pubmed:affiliationDepartment of Medicinal Chemistry, Amgen Inc., 360 Binney Street, Cambridge, MA 02142, USA. john.buchanan@amgen.comlld:pubmed
pubmed-article:21414779pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:21414779lld:chembl